共 50 条
- [1] Rewiring CD8+T cell responses to PD-1 immune checkpoint blockade in PDAC by preventing terminal exhaustion via the inhibitory receptor PSGL-1CANCER RESEARCH, 2024, 84 (06)Hope, Jennifer L.Zhang, YijuanHetrick, Hannah A.Romano, GabrieleRoy, SreejaLin, MichellePalete, Ashley B.Maganti, SwethaOtero, Dennis C.Commisso, CosimoBradley, Linda M.
- [2] PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition Synergize to Reinvigorate Exhausted T CellsFRONTIERS IN IMMUNOLOGY, 2022, 13Viramontes, Karla M.Neubert, Emily N.DeRogatis, Julia M.Tinoco, Roberto
- [3] PD-1 immune checkpoint blockade can synergize with PSGL-1 inhibition to reinvigorate exhausted T cellsJOURNAL OF IMMUNOLOGY, 2023, 210 (01):Viramontes, Karla M.Neubert, Emily N.DeRogatis, Julia M.Henriquez, MoniqueTinoco, Roberto
- [4] Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapyNATURE, 2023, 615 (7953) : 697 - +Puig-Saus, CristinaSennino, BarbaraPeng, SongmingWang, Clifford L.Pan, ZhengYuen, BenjaminPurandare, BhaminiAn, DuoQuach, Boi B.Nguyen, DianaXia, HuimingJilani, SameehaShao, KevinMcHugh, ClaireGreer, JohnPeabody, PhillipNayak, SaparyaHoover, JonathanSaid, SaraJacoby, KyleDalmas, OlivierFoy, Susan P.Conroy, AndrewYi, Michael C.Shieh, ChristineLu, WilliamHeeringa, KatharineMa, YanChizari, ShahabPilling, Melissa J.Ting, MarcTunuguntla, RamyaSandoval, SalemizMoot, RobertHunter, TheresaZhao, SidiSaco, Justin D.Perez-Garcilazo, IvanMedina, EgmidioVega-Crespo, AgustinBaselga-Carretero, IgnacioAbril-Rodriguez, GabrielCherry, GraceWong, Deborah J.Hundal, JasreetChmielowski, BartoszSpeiser, Daniel E.Bethune, Michael T.Bao, Xiaoyan R.Gros, Alena
- [5] Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapyNature, 2023, 615 : 697 - 704Cristina Puig-SausBarbara SenninoSongming PengClifford L. WangZheng PanBenjamin YuenBhamini PurandareDuo AnBoi B. QuachDiana NguyenHuiming XiaSameeha JilaniKevin ShaoClaire McHughJohn GreerPhillip PeabodySaparya NayakJonathan HooverSara SaidKyle JacobyOlivier DalmasSusan P. FoyAndrew ConroyMichael C. YiChristine ShiehWilliam LuKatharine HeeringaYan MaShahab ChizariMelissa J. PillingMarc TingRamya TunuguntlaSalemiz SandovalRobert MootTheresa HunterSidi ZhaoJustin D. SacoIvan Perez-GarcilazoEgmidio MedinaAgustin Vega-CrespoIgnacio Baselga-CarreteroGabriel Abril-RodriguezGrace CherryDeborah J. WongJasreet HundalBartosz ChmielowskiDaniel E. SpeiserMichael T. BethuneXiaoyan R. BaoAlena Gros
- [6] Antibody blockade of the PSGL-1 immune checkpoint enhances T-cell responses to B-cell lymphomaIMMUNOTHERAPYLeukemia, 2025, 39 (1) : 178 - 188João L. PereiraLiliana AredeFrancisca FerreiraAndreia MatosDulcineia PereiraRita F. SantosAlexandre M. CarmoMaria J. OliveiraJosé C. MachadoDelfim DuarteNuno R. dos Santos
- [7] PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell ExhaustionIMMUNITY, 2016, 44 (05) : 1190 - 1203Tinoco, RobertoCarrette, FlorentBarraza, Monique L.Otero, Dennis C.Magana, JonathanBosenberg, Marcus W.Swain, Susan L.Bradley, Linda M.
- [8] PSGL-1 Immune Checkpoint Inhibition for CD4+ T Cell Cancer ImmunotherapyFRONTIERS IN IMMUNOLOGY, 2021, 12DeRogatis, Julia M.Viramontes, Karla M.Neubert, Emily N.Tinoco, Roberto
- [9] Fibroblast activation protein (FAP)-targeted radiotherapy increases tumor CD8+ T cell infiltration and enhances response to PD-1 immune checkpoint blockadeCANCER RESEARCH, 2023, 83 (07)Zboralski, DirkHohne, AileenChristensen, EsbenPaschke, MatthiasRobillard, LilianeSimmons, Andrew D.Osterkamp, FrankHarding, Thomas C.Nguyen, Minh
- [10] Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responsesIMMUNITY, 2022, 55 (03) : 512 - +Banta, Karl L.Xu, XiaozhengChitre, Avantika S.Au-Yeung, AmeliaTakahashi, ChikaraO'Gorman, William E.Wu, Thomas D.Mittman, StephanieCubas, RafaelComps-Agrar, LaetitiaFulzele, AmitBennett, Eric J.Grogan, Jane L.Hui, EnfuChiang, Eugene Y.Mellman, Ira